Condensed Statement of Shareholders' Deficiency	3 Months Ended
	Apr. 30, 2016 USD ($) shares
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shareholders' deficiency, Beginning balance	$ (421,404)
Common stock, shares outstanding, Beginning balance | shares	1,233,853
Net loss	$ (18,729)
Shareholders' deficiency, Ending balance	$ (440,133)
Common stock, shares outstanding, Ending balance | shares	1,233,853
Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shareholders' deficiency, Beginning balance	$ 1,233
Common stock, shares outstanding, Beginning balance | shares	1,233,853
Shareholders' deficiency, Ending balance	$ 1,233
Common stock, shares outstanding, Ending balance | shares	1,233,853
Additional Paid-in Capital
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shareholders' deficiency, Beginning balance	$ 81,323
Shareholders' deficiency, Ending balance	81,323
Accumulated Deficit
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shareholders' deficiency, Beginning balance	(503,960)
Net loss	(18,729)
Shareholders' deficiency, Ending balance	$ (522,689)